Five-Year Assessment of Time of Sputum Smears Conversion and Outcome and Risk Factors of Tuberculosis Patients in Central Iran

Table 1

Comorbidities and demographic and bacteriological variables of sputum smear positive pulmonary tuberculosis patients in Yazd ().

Characteristic		Number %
Sex	Male	114 (54)
Age	≤50	86 (40.7)
	>50	125 (59.3)
Nationality	Iranian	110 (52.1)
	Non-Iranian	101 (47.9)
Initial sputum grading	1+	122 (57.8)
	2+	36 (17.1)
	3+	53 (25.1)
Accompanying disease	DM	20 (9.5)
	HIV	4 (1.9)
	Malignancy	1 (0.5)
	Transplant	2 (0.9)
	Others^*	10 (4.7)
Treatment regimen	HRZE	185 (87.7)
	HRZES	18 (8.5)
	HRE	6 (2.8)
	HZE	2 (0.9)
Treatment category	CAT I	191 (90.5)
	CAT II	20 (9.5)

 ^*Corticosteroid therapy (3), COPD (3), chronic renal failure (2), inherited cell mediated immunodeficiency (1), and cirrhosis (1). H: isoniazid; R: rifampicin; Z: pyrazinamide; E: ethambutol; S: streptomycin.